The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
March 2018 (Volume 96)
Gail R. Wilensky Read Bio
Back to The Milbank Quarterly
With control of both houses of Congress and the White House, many Republicans, as well as a large segment of the American public assumed Republicans would make good on their pledge to “repeal and replace” the Affordable Care Act (ACA)—including its expansion of the Medicaid program to anyone below 138% of the poverty line. What soon became clear, however, is that the estimated losses by the Congressional Budget Office of 20+ million of the newly insured that would result from replacement legislation, along with the concerns of Republican governors and other state officials about the loss of the added Medicaid dollars that had been associated with the ACA, made “repeal and replace” politically untenable. Recent polling has also shown surprisingly strong support for Medicaid: 74% of the public holds a favorable view of Medicaid, including 37% who say they hold a “very favorable” view. A total of 61% say the program is working well for most low-income people and an even higher number—67%—say the program is working well for most low-income people in their state.1 Another poll from 2015 found that two-thirds (64%) of Americans reported a connection at some point in their lives to Medicaid and a vast majority (87%) are against spending cuts to the program.2
The strong general support for Medicaid doesn’t mean that the public doesn’t recognize the need or desirability for some changes to the financing or structure of Medicaid. The same survey indicated that the public is very supportive of some changes—such as requiring states to impose work requirements for Medicaid beneficiaries (70% support) or requiring drug testing (64%). However, it is less supportive of other changes—such as reducing federal funding for the Medicaid expansion (35%) or for changing the funding to limit how much states get each year (35%).
There are some changes to the Medicaid program that may be easier to convince the public would improve the program than changing the structure or financing. For example, Medicaid could begin requiring outcome metrics be provided by the states rather than focusing exclusively on process and procedural assurances. Most areas of coverage, such as Medicare or private-sector insurance, are gradually moving away from an exclusive focus on inputs and process to one that takes account of “value”—that is, the outcomes associated with specific care interventions relative to their costs. Although there continues to be more “talk than action,” with most payments to physicians still being made on the basis of fee-for-service reimbursement, increasing numbers of Medicare payments have at least some component in their payment that is related to “value.” The private sector is also focusing on outcomes and value-based payments to providers and sometimes the premiums or coinsurance payments charged for particular uses of care as well. Outcome metrics for Medicaid might include the incidence of low birth weight infants, the percent of deliveries that occur vaginally, immunization rates for two-year-olds, and so forth.
Another change to improve Medicaid that is likely to win public support is to have better coordination between Medicare and Medicaid for the small but very expensive population that is on both Medicare and Medicaid. Because the rules associated with Medicare and Medicaid differ substantially and the funding streams differ as well—all federal monies for Medicare versus a blend of federal and state monies for Medicaid—they have tended to operate as separate programs subject to separate reporting and process requirements. Providing for easier cooperation between the programs so that care could be more easily integrated could potentially improve the quality and reduce the costs of caring for this frail, elderly population. One challenge, aside from the different rules that govern each program, is that most of the savings will occur because of actions taken at the local level where care is provided but because of the way both programs are financed, most of the savings will accrue to the federal government. The federal government will need to share some of the savings that are produced as a result of local interventions or they are unlikely to happen.
There should also be an effort to reduce the administrative burden on states from Medicaid and to allow for more rapid innovation. While Medicaid is a highly flexible program through its use of waivers, getting a waiver request from the Centers for Medicare and Medicaid Services is an expensive and time-consuming process. Finding ways to expedite the waiver process would reduce the cost and frustration states frequently experience when they try to innovate.
One past concern regarding Medicaid that has not been an issue thus far with the expansion states is the states’ use of “creative financing” strategies to sharply reduce their share of Medicaid funding.3 In a 2014 report, the Government Accountability Office estimated that questionable state revenue represented 26% of the match funds. It hasn’t been an issue with the expansion population because the federal government funded 100% of the costs of the expansion population from 2014 to 2016. That funding is now on a declining path to reach a 90% match by 2020. The interest in states finding ways to minimize their share of the Medicaid costs can be expected to increase as they are required to cover 10% of the costs of the expansion population, which for some states can be a sizable population. If there is an effort to move states to a single match rate representing a blend of the federal match rate for the base Medicaid population, which varies between 50% and 73%, and the 90% match for the expanded Medicaid population, that would provide an even greater incentive for states to find ways to reduce their share of the match.
One way to reduce the incentive for creative financing is a per capita cap. Not one that is designed to remove $800-$900 billion dollars from the program over a decade, as was proposed as part of the House American Health Care Act of 2017, but a program that keeps spending close to current predictions. Because the expansion and nonexpansion states currently receive such different amounts of federal Medicaid money with correspondingly different coverage rates, a baseline amount would have to allow for some adjustment to be made—either spreading the expansion funds across all 50 states or putting more federal money in. Another key issue, besides the baseline, is the rate of increase in funding that should occur. The rate of increase should approximate what an efficient state would need to spend (perhaps something between the consumer price index [CPI] and CPI-M, the medical CPI) and should be adjusted for the different populations covered under Medicaid—that is, the nondisabled population under age 65, the disabled population, and the dual eligible population.
Per capita caps got a bad reputation earlier in 2017 but it was the amount that was being removed from the program that should have been the focus of the public’s ire—not the concept. Medicaid is now the only open-ended entitlement left in the federal government—at least as long as IPAB (the Independent Payment Advisory Board) is on the books. It’s time that Medicaid also changes.
Gail R. Wilensky, PhD, is an economist and senior fellow at Project HOPE, an international health foundation. She directed the Medicare and Medicaid programs and served in the White House as a senior adviser on health and welfare issues to President Georege HW Bush. She was also the first chair of the Medicare Payment Advisory Commission. Her expertise is on strategies to reform health care, with particular emphasis on Medicare, comparative effectiveness research, and military health care. Wilensky currently serves as a trustee of the Combined Benefits Fund of the United Mine Workers of America and the National Opinion Research Center, is on the Board of Regents of the Uniformed Services University of the Health Sciences (USUHS) and the Board of Directors of the Geisinger Health System Foundation, United Health Group, Quest Diagnostics and Brainscope. She is an elected member of the Institute of Medicine, served two terms on its governing council and chaired the Healthcare Services Board. She is a former chair of the board of directors of Academy Health, a former trustee of the American Heart Association and a current or former director of numerous other non-profit organizations. She received a bachelor’s degree in psychology and a PhD in economics at the University of Michigan and has received several honorary degrees.
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, historical, legal, and ethical dimensions of health and health care policy.